Name:
Benjamin Eric Blass
Country:
USA
City:
Eagleville
State/Province:
PA
ACS Member:
Member
Local Section:
L304,Philadelphia
International Chapter:
Technical Division Membership:
D518,Medicinal Chemistry Division;D521,Organic Chemistry Division
Technical Division Membership Emeritus:
Subdivision Member:
ACS Activities:
Company/Institution Name:
Career Stage:
Professional
Research and Special Interests:
Career Highlights:
A) Kv1.5 blocker for atrial arrhythmia chemistry team leader: IND candidate KVI-020 and back-up equity compounds developed (Pfizer/Wyeth, Metabolic Disease, 2006-present)
B) Transient receptor potential vanilliod 1 (TRPV1) antagonist project senior team member: (Pfizer/Wyeth, CNS, 2008-present)
C) Lead Discovery Section Group Leader: 8-12 direct reports, multiple project leadership roles, high through-put synthesis (P&G Pharmaceuticals, Discovery Chemistry, 2001-2006)
D) Organic Colloquium Committee Chairman, annual corporate recruiting and community outreach event (P&G Pharmaceuticals, Discovery Chemistry, 1999-2006)
E) Corporate Chemistry Contact, chemistry representative for contract negotiation with Aldrich, VWR (P&G Pharmaceuticals, Discovery Chemistry, 1999-2006)
F) Extensive publication track record:14 patents and patent applications, 33 publications, presentations and invited lectureships
Area of Expertise:
Medicinal chemistry, hit to lead optimization, drug discovery, microwave chemistry, parallel synthesis, solid supported reagents, project team leadership.
Years of Expertise:
16-20